BI-3812 free base · Synonyms: BI 3812 · BI3812

BI-3812 is potent and efficacious BCL6 inhibitor.

For research use only. Not for human or veterinary use.

Target BCL6

Research area Cancer

Purity >98% Stock Inquire

Data Sheet SDS COA

BI-3812 structure

CAS No.: 2166387-64-8

Pack sizes & pricing

Size	Price	SKU	Stock
50 mg	USD 480.00	BP-01980-50mg	In stock	Get quote
100 mg	USD 760.00	BP-01980-100mg	In stock	Get quote
250 mg	USD 1,140.00	BP-01980-250mg	In stock	Get quote
500 mg	USD 1,620.00	BP-01980-500mg	In stock	Get quote
1 g	USD 2,280.00	BP-01980-1g	In stock	Get quote

Need another size or custom synthesis? Request a quote.

BI-3812 is potent and efficacious BCL6 inhibitor, inhibiting the BTB domain of BCL6, with an IC50 of ≤3 nM; BI-3812 has antitumor activity.

In Vivo BI-3812 is a BCL6 inhibitor, with an IC50 of ≤ 3 nM. BI-3812 shows an IC50 of 40 nM for the cellular BCL6.

SMILES: CNC(=O)COC1=CC2=C(N(C)C1=O)C(OC)=CC(NC1=NC(=NC=C1Cl)N1CCC(CC1)C(=O)N(C)C)=C2
InChIKey: XCGYXEVLQIIEJH-UHFFFAOYSA-N

MW (average): 558.0290
Formula: C₂₆H₃₂ClN₇O₅
CAS No.: 2166387-64-8
Physical state: Solid
Color: Off-white to pink
Shipping: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage: Powder -20℃ 2 years; In solvent -20℃ 1 month;

Soluble in DMSO

[1]. Kerres N, et al. Chemically Induced Degradation of the Oncogenic Transcription Factor BCL6. Cell Rep. 2017 Sep 19;20(12):2860-2875.

Search Cancer